VNS Therapy™ for Epilepsy

LivaNova PLC is a global medical technology company that specializes in neuromodulation treatments. Their primary product, the VNS Therapy System, is designed for patients with drug-resistant epilepsy who do not achieve adequate seizure control with medication alone. This FDA-approved therapy has been in clinical use for over two decades and has helped more than 16,000 patients worldwide. The VNS Therapy System consists of an implantable pulse generator that stimulates the left vagus nerve, delivering electrical impulses to modulate brain activity. This device can be programmed for automatic or manual stimulation, allowing for tailored treatment. Clinical evidence shows that VNS Therapy significantly reduces seizure frequency and improves the quality of life for both adult and pediatric patients. LivaNova also offers extensive support and resources for healthcare providers and patients to ensure effective therapy adoption and management.

• Employees 9